Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

Published:2011-03-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Oliveri Roberto S¹,Wetterslev Jørn²,Gluud Christian³

Affiliation:

1. The Finsen Centre, section 5073, Rigshospitalet; Department of Oncology; Blegdamsvej 9 Copenhagen Denmark DK-2100

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Blegdamsvej 9 Copenhagen Denmark DK-2100

3. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004787.pub2/fullpdf

Reference106 articles.

1. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial;Akamatsu;Liver International,2004

2. Bruix J Llovet JM Castells A Bru C Montanya X Vilana R Treatment of hepatocellular carcinoma by transarterial embolization (TAE). A prospective placebo controlled trial [abstract] Hepatology 1997 249A

3. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution;Bruix;Hepatology,1998

4. Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma;Cheng;Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology],2004

5. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Federation Francophone de Cancerologie Digestive 9402);Doffoël;European Journal of Cancer,2008

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study;European Journal of Oncology Nursing;2023-10

2. Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study;Radiology and Oncology;2023-07-26

3. Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil;Journal of Medical Economics;2023-05-24

4. Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia;Diagnostic and Interventional Imaging;2023-03

5. Smart nanoparticles and microbeads for interventional embolization therapy of liver cancer: state of the art;Journal of Nanobiotechnology;2023-02-06